TITLE

Drug Compliance and Persistence -- A Major Public Health Problem

AUTHOR(S)
Karpman, Harold L.
PUB. DATE
December 2009
SOURCE
Internal Medicine Alert;12/29/2009, Vol. 31 Issue 24, p186
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Patients who adhered to prescribed antihypertensive medication experienced a significantly decreased risk of acute cardiovascular events, yet only 6 months after diagnosis, only 8.1% of patients were classified as having high adherence, 40.5% demonstrated intermediate adherence, and 51.4% demonstrated low adherence to prescribed medication regimens.
ACCESSION #
47507395

 

Related Articles

  • Which strategy best bet for improving patient adherence?  // PharmacoEconomics & Outcomes News;10/30/2010, Issue 615, p9 

    The article discusses research on improving adherence of cardiovascular disease (CVD) patients to treatments, which references the study "The Modeled Lifetime Cost-Effectiveness of Published Adherence-Improving Interventions for Antihypertensive and Lipid-Lowering Medications," by R. H. Chapman...

  • Conveying the concept of risk. Procter-King, Jan // Pulse;4/13/2011, Vol. 71 Issue 13, p27 

    The article discusses the ways to explain the complex concepts of cardiovascular (CVR) risk to patients in Great Britain. It mentions that several studies were held to weight the reception and compliance of patients being informed on the possible CVR risk to motivate godly compliance of...

  • Monitoring one-year compliance to antihypertension medication in the Seychelles. Bovet, Pascal; Burnier, Michel; Madeleine, George; Waeber, Bernard; Paccaud, Fred // Bulletin of the World Health Organization;2002, Vol. 80 Issue 1, p33 

    Objective To examine the compliance to medication among newly diagnosed hypertensive patients screened from the general population of the Seychelles, a rapidly developing country. Methods Among the 1067 participants to a population-based survey for cardiovascular risk factors, hypertension was...

  • Low-Dose AspirinTherapy forCardiovascular Prevention. Herlitz, Johan; Tóth, Peter P.; Næsdal, Jørgen // American Journal of Cardiovascular Drugs;2010, Vol. 10 Issue 2, p125 

    Long-term therapy with low-dose aspirin (acetylsalicylic acid; ASA), 75-325 mg, is highly effective for the secondary prevention of cardiovascular (CV) events. For high-CV-risk patients to attain the full benefits of this therapy, it is important that treatment is continuous and that good...

  • Hypertension Detection and Compliance: Permanent Site Hypertensive Evaluation -- A New Method of Increasing Patient Compliance. Hutchison, James C. // Angiology;Aug1979, Vol. 30 Issue 8, p568 

    Screening is successful in detecting hypertension, but reducing morbidity and mortality depends on achieving patient compliance. Cardiovascular disease has declined significantly since the thiazide diuretics have become generally available and provided effective and safe treatment of...

  • A New Description of Arterial Function: The Compliance-Pressure Loop. Li, John K.-J. // Angiology;Jul1998, Vol. 49 Issue 7, p543 

    Hypertension and atherosclerosis are associated with reduced arterial compliance, which is the principal component that reflects the dynamic behavior of the arterial system. Hence, change in arterial compliance has been used as a compass of arterial wall properties, as well as an effective...

  • Why patients don't take their meds.  // Cortlandt Forum;7/25/2005, Vol. 18 Issue 7, p16 

    Presents a graph explaining why hypertensive patients fail to take their medications in the U.S.

  • Resistant disease or resistant patient: Problems with adherence to cardiovascular medications in the elderly. Mann, Devin M. // Geriatrics;Sep2009, Vol. 64 Issue 9, p10 

    When faced with difficult-to-control cardiovascular risk factors, clinicians need to address the potential role of patient adherence to medication. Among the elderly in particular, careful consideration must be paid to accurately diagnosing an adherence problem in the context of often worsening...

  • Systemic lupus erythematosus and cardiac risk factors: medical record documentation and patient adherence. Bengtsson, C; Bengtsson, AA; Costenbader, KH; Jönsen, A; Rantapää-Dahlqvist, S; Sturfelt, G; Nived, O // Lupus;Oct2011, Vol. 20 Issue 10, p1057 

    This study explores patients’ knowledge of cardiac risk factors (CRFs), analyses how information and advice about CRFs are documented in clinical practice, and assesses patient adherence to received instructions to decrease CRFs. Systemic lupus erythematosus (SLE) patients...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics